Strategic Advocates’s CureVac CVAC Stock Holding History

Strategic Advocates’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,209	Closed	-$14.4K	–	339
2025 Q4	$14.4K	Hold	3,209	–	–	﹤0.01%	324
2025 Q3	$17.3K	Buy	+3,209	New	+$17.4K	﹤0.01%	302

Strategic Advocates's CVAC Position: Q1 2026 in Review

Strategic Advocates sold out of CureVac (CVAC) in Q1 2026, closing a stake of 3,209 shares — an estimated $14.4K sold.

Strategic Advocates first reported a position in CVAC in Q3 2025 and held it in 2 quarters. The position peaked at $17.3K in Q3 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

Strategic Advocates reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
Strategic Advocates sold 3,209 CureVac shares in Q1 2026, an estimated $14.4K.
Strategic Advocates first reported a position in CureVac in Q3 2025 and held it in 2 quarters.
Strategic Advocates's CureVac position peaked at $17.3K in Q3 2025.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.